Venture Life trims losses as ageing-population treatments gain traction

Oliver Haill Sharecast | 25 Mar, 2015 14:11 - Updated: 16:16 | | |

pensiones
  • 8,832.75
  • -1.03%-91.72
  • Max: 8,931.04
  • Min: 8,803.21
  • Volume: 0
  • MM 200 : n/a
17:18 20/10/17
  • 1,020.33
  • -0.15%-1.49
  • Max: 1,023.33
  • Min: 1,020.16
  • Volume: 0
  • MM 200 : n/a
17:20 20/10/17
  • 57.50
  • 0.00%0.00
  • Max: 57.50
  • Min: 57.50
  • Volume: 0
  • MM 200 : n/a
17:18 20/10/17

Full year results from consumer healthcare company Venture Life showed the first notable revenues for the company since it floated on AIM last March.

Group revenues were transformed by the acquisition of Italian cosmetics manufacturer Biokosmes at the time of the flotation, rocketing to £7.2m from the £0.49m the prior year, with losses before tax, amortisation and exceptional costs slashed to £0.59m from £0.96m.

The manufacturing business, which is centred around Biokosmes, contributed revenues of £6.7m at a gross margin of 35%, meaning the historic brands business enjoyed organic revenue growth of around 2%.

As the manufacturing facility is running at less than 50% of its potential capacity, with only limited investment required to be operating at its potential capacity, management is optimistic of further gains.

The company's historic UK-based brands business, which develops and commercialises self-care products that address 'quality of life' healthcare needs of the ageing population, had 15 products on its roster by the year-end, with 17 new distribution agreements signed in 2014, followed by a post-period-end agreement with major Chinese skincare retailer Gialen.

Notable developments in the year included the first European launch of the company's new Benecol food supplement in capsule form, plus a 10-year exclusive distribution agreement with Valeant for Venture Life's Procto-eze haemorrhoid treatment in six European markets, including Germany.

Chief executive Jerry Randall said: "With the acquisition of Biokosmes and listing on AIM, our focus in 2014 was to structure the business to deliver sustainable and strong long term growth."

He acknowledged that the weakening euro may make the pricing of our products more attractive to buyers outside the Eurozone, but may negatively affect reported numbers in sterling for 2015.

Nevertheless Randall expects 2015 to be a year of "material top-line growth on a like-for-like basis" as distribution agreements signed in recent months begin to deliver new revenues in addition to repeat business and as the positive impact of recent investment in business development in both the brands and manufacturing businesses.

More news

20 Oct FX round-up: Dollar boosted by tax plans, pound rallies on Brexit hopes

President Donald Trump's tax reforms made the dollar the early story, before a sterling narrative took over as Brexit developments filtered through from the EU 27 in Brussels.

20 Oct President Trump wrongly links rise of UK crime to 'radical Islamic terror'

US President Donald Trump was accused of fuelling hate crimes after he said the UK crime rate was linked to "radical Islamic terror".

20 Oct Europe close: Stocks end near session lows despite US tax reform optimism

European stocks finished near their worst levels of the day despite optimism regarding prospects for the US economy.

20 Oct London close: Footsie ends flat as pound bounces back

London stocks finished the Friday session almost exactly flat despite encouraging noises emerging from Brussels mingled with optimism stateside over proposed tax reforms.

20 Oct Berenberg ups Cobham target but says premium valuation "unwarranted"

Despite Cobham share's outperformance over the past six months, Berenberg cautioned clients about the near-term strength of various of the firm's end-markets, alongside operational challenges that would require time to resolve and, for a time, scupper hopes that the dividend would be reinstated.

20 Oct Octagonal 'extremely pleased' as it reports record revenue and profits

Octagonal updated the market on its trading on Friday, based on the unaudited interim figures for the six months to 30 September for its wholly-owned subsidiary, Global Investment Strategy UK, saying it was “extremely pleased” with the record revenues and profits achieved.

20 Oct Marlowe trading in line as acquisitions integrate 'well'

Support services group Marlowe updated the market on its trading for the six months to 30 September on Friday, saying trading in the first six months of the financial year was in line with board expectations.

20 Oct Ncondezi agrees non-binding development offer with CMEC and GE

Ncondezi Energy announced on Friday that it has agreed - in principle - to the terms of a non-binding offer with China Machinery Engineering Corporation and General Electric South Africa to enter into exclusive negotiations to develop, construct and operate the integrated Ncondezi 300MW coal-fired power project and open pit coal mine in Tete, Mozambique.

20 Oct Virgin Money's growth prospects not reflected in share price, Barclays says

Analysts at Barclays Research believe Virgin Money's growth prospects are not reflected in the share price.

20 Oct Bacanora clears regulatory hurdle at Sonora lithium project

Lithium exploration and development company Bacanora Minerals announced on Friday that the environmental impact statement - the ‘manifestacion de impacto ambiental’ (MIA) - for its flagship Sonora Project in Mexico has been approved by SEMARNAT, the Environment Ministry of Mexico.